Rice Hall James & Associates LLC Invests $4.29 Million in Addus HomeCare Corporation $ADUS

Rice Hall James & Associates LLC acquired a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 42,704 shares of the company’s stock, valued at approximately $4,290,000.

Other large investors have also bought and sold shares of the company. Leeward Investments LLC MA boosted its position in shares of Addus HomeCare by 9.4% during the 1st quarter. Leeward Investments LLC MA now owns 120,857 shares of the company’s stock valued at $11,318,000 after purchasing an additional 10,414 shares in the last quarter. Bank of America Corp DE grew its stake in shares of Addus HomeCare by 11.3% in the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after purchasing an additional 32,714 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Addus HomeCare by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 1,308,605 shares of the company’s stock worth $140,531,000 after purchasing an additional 10,501 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Addus HomeCare by 176.0% in the 1st quarter. SG Americas Securities LLC now owns 27,303 shares of the company’s stock worth $2,557,000 after purchasing an additional 17,411 shares in the last quarter. Finally, Dean Capital Management acquired a new stake in Addus HomeCare during the first quarter valued at approximately $2,837,000. Institutional investors own 95.35% of the company’s stock.

Insider Buying and Selling at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the transaction, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ADUS. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Barclays raised their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research note on Wednesday, July 8th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $114.90 on Tuesday. The company has a market capitalization of $2.15 billion, a price-to-earnings ratio of 20.16, a P/E/G ratio of 1.56 and a beta of 0.87. Addus HomeCare Corporation has a 1-year low of $87.95 and a 1-year high of $124.43. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock’s fifty day simple moving average is $107.32 and its 200-day simple moving average is $102.01.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million during the quarter, compared to the consensus estimate of $376.24 million. During the same period in the prior year, the business earned $1.49 EPS. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, sell-side analysts predict that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.